Indicative of a larger embrace of healthcare applications, telemedicine is on the rise as healthcare providers are meeting consumer demand for cheaper, more accessible care available within minutes.
This week, digital healthcare leader Zava confirmed a Series A investment of $32 million to expand into statutory healthcare systems in Germany, UK and France. The London-based startup’s funding round was led by growth equity firm HPE Growth.
“In a world of an ageing population and rising costs, healthcare systems are at a breaking point. Barriers are put in people’s way and stop them getting the support they need. Zava exists to break down these barriers - costs, access & information.”
David Meinertz, Zava co-founder and CEO states: “In a world of an ageing population and rising costs, healthcare systems are at a breaking point. Barriers are put in people’s way and stop them getting the support they need. Zava exists to break down these barriers - costs, access & information...Zava’s mission is to build healthcare that is accessible, dependable and a fraction of today’s cost.”
Clinical questionnaires streamline patient-doctor interactions, saving time for both parties without compromising quality and safety. Founded in 2011, the company has provided three million paid consultations across six markets in Europe, with the last 1 million taking place in 2018. Zava averages 100,000 monthly patients from the UK, Germany, France, Austria, Switzerland and Ireland who turn to the platform for medical advice and treatment.
Plans for the investment include team growth and market expansion, first in existing markets, then across Europe and finally, worldwide.
Harry Dolman, Partner at HPE Growth, said in a statement: “Zava offers a unique and highly scalable model to deliver a more convenient healthcare experience to patients while radically improving the efficiency of healthcare professionals, enabling healthcare systems to reduce the overall costs associated with primary care.”
